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1. Introduction
  Mangiferin, C19H18O11, a glucoxanthone (1,3,6,7-
tetrahydroxyxanthone- C2-毬-D-glucoside) has been 
reported to be present in various parts of Mangifera indica 
viz leaves[1], fruits, stem bark, roots[2] and heartwood[3]. 
Mangiferin has attracted considerable interest in view 
of its numerous pharmacological activities, including 
antibacterial[3], antitumor, immunomodulatory and 
antiHIV[4], antidiabetic[5], antioxidative[6], anthelminthic, 
antiallergic[7] and antiinflammatory activity[8], antiviral[9], 
inducer of macrophage activation[10]. In Cuba, mangiferin 
is traditionally used as an antiinflammatory, analgesic 
and also as an antioxidant under brand name Vimang®. 
In Sri Lanka, mangiferin is used in the obesity treatment 
and particularly for diabetes type Ⅱ under brand name 
Salaretin®.
  Updated literature survey reveals that much attempts 
have not been made to make the derivatives of mangiferin. 
Secondly, amino methylation of xanthone glycoside is 
one method which has yielded derivatives of xanthone 
glycosides successfully. Working on the same guidelines, 
it was decided to subject mangiferin also to this chemical 
modification ie. aminomethylation. Further, unlike 
anti-inflammatory and analgesic property, the possible 
antipyretic activity of neither mangiferin nor its derivatives 
has been studied to our best knowledge. This prompted 
us to investigate upon mangiferin and its derivatives for 
their antipyretic activity which can possibly open a new 
therapeutic use of these compounds.
Objective: To screen different analogues of mangiferin pharmacologically for antipyretic activity. 
Methods: The naturally occurring xanthone glycoside mangiferin was isolated by column 
chromatography from the ethanolic extract of stem bark of Mangifera indica. Mangiferin was 
further converted to 5-(N-phenylamino methyleno) mangiferin, 5-(N-p-chlorophenylamino 
methyleno) mangiferin, 5-(N-2-methyl phenylamino methyleno) mangiferin, 5-(N-p-methoxy 
phenylamino methyleno) mangiferin, 5-(N, N-diphenylamino methyleno) mangiferin, 5-(N-
毩-napthylamino methyleno) mangiferin and 5-(N-4-methyl phenylamino methyleno) mangiferin 
analogues. The synthesized compounds were further screened for antipyretic activity along with 
mangiferin at a dose level of 100 and 200 mg/kg. Mangiferin and its analogues were characterized 
by melting point and Rf value determination and through spectral technique like UV, IR, and 
NMR spectral analysis. Results: The antipyretic activity of mangiferin as well as all analogues 
was found to be more significant in at higher dose ie. 200 mg/kg which was depicted through a 
decrease in rectal temperature up to 3 h. Conclusions: The antipyretic activity of mangiferin and 
its analogues may be attributed to inhibition in synthesis of TNF-毩 and anti-oxidant activity 
associated with amelioration of inflammatory actions of cytokines.
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2. Materials and methods
  The stem bark of Mangifera indica cultivar desi which 
was collected from saunda village Modinagar, Ghaziabad 
district of U.P. in the month of April 2006, was authenticated 
at the Department of Botany, M. M. P. G. College, Modinagar. 
Melting points were determined in open capillary tubes and 
purity of the compounds was checked by TLC on silica gel 
G. UV spectra were recorded on Systronics double beam UV 
spectrophotometer 2202, IR spectra were recorded in KBr on 
Jasco FTIR 4100 spectrophotometer, NMR spectra on Bruker 
avance II-400 MHz, spectrometer using TMS as internal 
reference. The student's paired t-test (two tailed) was used 
to analyse significant differences between the control and 
experimental groups by using the GraphPad Prism version 
5.0 for Windows (GraphPad Software, Inc., 2009). Data are 
expressed as mean 依 SEM. 
2.1. Defatting of coarsely powdered bark
  The bark was dried at room temperature and coarsely 
powdered. The fresh air-dried and coarsely powdered 
bark of Mangifera indica was extracted exhaustively with 
petroleum ether (60-80 ℃) in Soxhlet apparatus to remove 
fatty matter for 56 h. 
2.2. Extraction of mangiferin
  Coarsely powdered bark of Mangifera indica was extracted 
exhaustively with ethanol (95%) in Soxhlet apparatus for 
56 h. The combined alcohol extracts were concentrated 
under reduced pressure. Then, yellow amorphous powder 
was obtained. 
2.3. Isolation of mangiferin
  The dried alcoholic extract was adsorbed on silica gel (60-
120 mesh) and chromatographed over silica gel column 
packed in petroleum ether (60-80 ℃). The column was 
eluted with chloroform︰methanol (1︰1) which gave 
mangiferin as a pale yellow amorphous powder. This upon 
crystallization from ethanol, produced pale yellow needle 
shaped mangiferin crystals. 
2.4. General method for the preparation of mangiferin 
analogues
  A mixture of equal mol of mangiferin, powdered 
paraformaldehyde and aromatic amine, 10 mL of 95% 
ethanol and 1 mL of concentrated hydrochloric acid 
was refluxed, cooled to room temperature and kept in a 
refrigerator overnight. The solid was filtered and washed 
with water and recrystallized from ethanol (Figure 1).
Figure 1. Synthesis of mangiferin analogues. 
2.5. Evaluation of antipyretic activity 
  Swiss albino mice were obtained from Central Animal 
House, Banaras Hindu University, Reg. No. 542/02/ab/
CPCSEA, weighing 25-30 g were given free access to 
semi synthetic balanced diet and water ad-libitum, with 
occasional supply of green vegetables (salad leaves). Mice 
were caged four per Perspex experimental cages at room 
temperature (22-25 ℃). Twelve hours of light and dark 
cycles were strictly followed in a fully ventilated room.
  The method described by Bisigano et al[11] was used. The 
animals were divided into sixteen groups of five animals 
each (n=5). Pyrexia was induced by subcutaneous injection 
of 20 mL/kg of 20% w/v freshly prepared aqueous suspension 
of Brewer’s yeast (BY) in normal saline (0.9% w/v NaCl) to 
mice below the nape of the neck. Mangiferin and analogues 
(100 mg/kg and 200 mg/kg), acetylsalicylic acid (150 mg/
kg) and equivalent volume of distilled water administered 
i.p. to mice in different groups of five animals. The rectal 
temperature was recorded using a rectal thermometer before 
beginning the experiment and immediately before and 1, 2 
and 3 h after drug administration.
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3. Results
3.1. Characterization of mangiferin
  Melting point: 269-270 ℃, Rf: 0.77 using n-butanol: acetic 
acid:water (4︰1︰2.2) as a Solvent system, 毸max: 205.6, 
256.8, 238.4, 315.2, 367.2 nm. IR (KBr) cm-1: 3 366(O-H), 
2 937(C-H), 1 649(斁C=O), 1 495(C=C), 1 253(-C-O), 1 050(C-
O-C). NMR (δppm): 13.81(ArOH intramolecularly bonded, 
1H), 7.9 (ArOH, 3H), 6.82 (Ar-H, 1H), 6.36 (Ar-H, 1H), 7.4 (ArH, 
1H), 2.5 (-C-OH, 4H), 3.7 (-CH-O-, 2H), 3.3 (-CH-, 2H), 3.5 
(-CH-, 3H).
3.1.1. 5-(N-phenylamino methyleno) mangiferin (M-1)
  Melting point: 190 ℃, Rf: 0.60, 毸max: 239.6, 261.2, 317.6, 
370.4 nm. IR (KBr) cm-1: 3 551(O-H), 3 319(N-H), 2 929(C-H), 
1 625(斁C=O), 1 488(C=C), 1 383(-C-N), 1 293(-C-O), 1 037(C-
O-C). NMR (δppm): 13.70 (ArOH intramolecularly bonded, 
1H), 8 (ArOH, 3H), 6.82 (Ar-H, 6H), 7.39 (Ar-H, 1H), 3.7 (Ar-
CH2-N-, 2H), 4.1 (Ar-NH-, 1H), 2.9 (-C-OH, 4H), 3.7 (-CH-O-, 
2H), 3.4 (-CH-, 1H), 3.5 (-CH-, 4H).
3.1.2. 5-(N-p-chlorophenylamino methyleno) mangiferin 
(M-2)
  Melting point: 210 ℃, Rf: 0.69, 毸max: 225.2, 228.8, 261.2, 
318.8, 368 nm. IR (KBr) cm-1: 3 410(O-H), 3 360(N-H), 
2 926(C-H), 1 625(斁C=O), 1 429(C=C), 1 375(-C-N), 1 295(-
C-O), 1 079(C-O-C), 715(C-Cl). NMR (δppm): 13.66 (ArOH 
intramolecularly bonded, 1H), 7.9 (ArOH, 3H), 6.82 (Ar-H, 5H), 
7.36 (Ar-H, 1H), 4.2 (Ar-CH2-N-, 2H), 4.0 (Ar-NH-, 1H), 2.1 
(-C-OH, 4H), 3.7 (-CH-O-, 2H), 3.4 (-CH-, 5H).
3.1.3. 5-(N-4-methyl phenylamino methyleno) mangiferin 
(M-3)
 Melting point: 195 ℃, Rf: 0.53, 毸max: 230, 261.2, 317.6, 
370.4 nm. IR (KBr) cm-1: 3 493(O-H), 3 483(N-H), 2 971(C-H), 
1 638   (斁C=O), 1 429(C=C), 1 283(-C-N), 1 044(C-O-C), 713. 
NMR (δppm): 13.66 (ArOH intramolecularly bonded, 1H), 7.9 
(ArOH, 3H), 6.82 (Ar-H, 5H), 7.36 (Ar-H, 1H), 2.3 (Ar-CH3, 3H), 
3.7 (Ar-CH2-N-, 2H), 4.2 (Ar-NH-, 1H), 2.3 (-C-OH, 4H), 3.7 
(-CH-O-, 2H), 3.3 (-CH-, 5H).
3.1.4. 5-(N-p-Methoxy phenylamino methyleno) mangiferin 
(M-4)
  Melting point: 190 ℃, Rf: 0.45, 毸max: 210.8, 224, 261.2, 
317.6, 370.4 nm. IR (KBr) cm-1: 3 536(O-H), 3 445(N-H), 
2 941(C-H),  1 646(斁C=O),  1 432(C=C),  1  283(-C-N), 
1 180(Ar-O-C), 1 078(C-O-C). NMR (δppm): 13.66 (ArOH 
intramolecularly bonded, 1H), 7.9 (ArOH, 3H), 6.8 (Ar-H, 1H), 
6.9 (Ar-H, 4H), 7.36 (Ar-H, 1H), 4.2 (Ar-CH2-N-, 2H), 4.0 (Ar-
NH, 1H), 3.8(Ar-O-CH3, 3H), 2.1 (-C-OH, 4H), 3.8 (-CH-O-, 2H), 
3.3 (-CH-, 5H).         
                    
3.1.5. 5-(N, N-Diphenylamino methyleno) mangiferin 
(M-5)
  Melting point: 210 ℃, Rf: 0.82, 毸max: 257.6, 240.8, 305.6, 
364.4 nm. IR (KBr) cm-1: 3 371(O-H), 2 931(C-H), 1 647(斁C=O), 
1 405(C=C), 1 297(-C-N), 1 253(-C-O), 1 031(C-O-C). NMR 
(δppm): 13.78 (ArOH intramolecularly bonded, 1H), 7.87 
(ArOH, 3H), 6.84 (Ar-H, 2H), 7.4 (Ar-H, 2H), 7.04 (Ar-H, 4H), 7.02 
(Ar-H, 4H), 3.9 (Ar-CH2-N-, 2H), 2.1 (-C-OH, 4H), 3.7 (-CH-O-, 
2H), 3.3 (-CH-, 2H), 3.4 (-CH-, 3H).
3.1.6. 5-(N-毩-Napthylamino methyleno)-mangiferin 
(M-6)
  Melting point: 205 ℃, Rf: 0.60, 毸max: 244.4, 297.2, 306.8nm. 
IR (KBr) cm-1: 3 443(O-H), 3 339(N-H), 2 927(C-H), 1 621(斁
C=O), 1 482(C=C), 1 385(-C-N), 1 290(-C-O), 1 038(C-O-C). 
NMR (δppm): 13.78 (ArOH intramolecularly bonded, 1H), 7.9 
(ArOH, 3H), 6.87 (Ar-H, 1H), 7.36 (Ar-H, 1H), 7.4 (napth-H, 5H), 
7.5 (napth-H, 2H), 4.29 (Ar-CH2-N-, 2H), 4.1(Ar-NH-, 1H), 2.1 
(-C-OH, 4H), 3.8 (-CH2-O-, 2H), 3.4 (-CH-, 5H).
3.2. Evaluation of antipyretic activity
  Table 1 showed that all the analogues of mangiferin 
along with acetyl salicylic acid (ASA) showed a significant 
reduction in rectal temperature up to 3 h. At initial stage ie. 
up to 1st h ASA, mangiferin, M-5 and M-6 showed a highly 
significant activity at both dose level ie.100 and 200 mg/
kg (P< 0.001), whereas in case of other analogues the same 
effect was observed only at 200 mg/kg. Further, at the end 
of 2nd phase all the analogues showed a significant effect 
Table 1
Antipyretic activity of mangiferin analogues in mice (℃).
Treatment Before treatment
After treatment
0 h 1 h 2 h 3 h
Control 38.76依0.05 38.65依0.05 38.76依0.05 38.60依0.04 38.61依0.05
ASA (150 mg) 38.80依0.04 38.70依0.04 38.13依0.02*** 37.45依0.12*** 36.31依0.01***
MG (100 mg) 38.86依0.03 38.75依0.03 38.13依0.04*** 37.38依0.03*** 37.07依0.01***
MG (200 mg) 38.86依0.03 38.85依0.03 37.87依0.05*** 36.76依0.03*** 36.33依 0.02***
M-1 (100 mg) 38.93依0.02 38.81依0.02 38.88依0.01 38.78依0.02*** 37.96依 0.03***
M-1 (200 mg) 38.92依0.02 38.82依0.02 38.73依0.02*** 38.38依0.15*** 37.20依0.02***
M-2 (100 mg) 38.86依0.02 38.75依0.02 38.381依0.01 38.59依0.02 37.68依0.20***
M-2 (200 mg) 38.88依0.02 38.66依0.01 38.59依0.02*** 38.36依0.01*** 37.23依0.02***
M-3 (100 mg) 38.85依0.03 38.83依0.03 38.54依 0.02* 38.41依0.04* 37.93依0.19***
M-3 (200 mg) 38.89依0.01 38.84依0.01 37.44依0.02*** 37.16依0.02*** 36.69依0.09***
M-4 (100 mg) 38.90依0.26 38.79依0.24 38.62依0.01 38.56依0.01 37.94依0.05***
M-4 (200 mg) 38.89依0.04 38.77依 0.04 37.88依0.06*** 36.98依0.08*** 36.53依0.28***
M-5 (100 mg) 38.89依0.02 38.77依0.01 38.59依0.02** 37.99依0.08*** 37.79依 0.10***
M-5 (200 mg) 38.82依0.03 38.62依0.03 37.92依0.07*** 37.53依0.11*** 36.51依0.04***
M-6 (100 mg) 38.87依0.03 38.86依 0.02 38.58依0.04*** 38.29依0.03*** 37.94依 0.02***
M-6 (200 mg) 38.66依0.02 38.65依 0.02 37.90依0.08*** 37.31依0.09*** 36.73依 0.04***
*indicates P< 0.05, ** indicates P < 0.01, *** indicates P < 0.001 compared to temperature before treatment.
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at both dose level (P< 0.001) except for M-3 (100 mg/kg) 
which was found to be less significant  (P< 0.05) while M-2 
(100 mg) and M-4 (100 mg) were not found to be significant. 
At the end of 3rd phase all the analogue showed a significant 
reduction in the rectal temperature (P< 0.001).
 
4. Discussion 
  In the process of isolation of mangiferin, stem bark of 
Mangifera indica was defatted with petroleum ether (60-
80 ℃) prior to extraction with ethanol 95%. The extract was 
chromatographed over silica gel and eluted with chloroform: 
methanol (1︰1) to afford the parent mangiferin as pale 
yellow needle shaped crystals.  Mangiferin analogues 
such as 5-(N-phenylamino methyleno) mangiferin, 5-(N-
p-chlorophenylamino methyleno) mangiferin, 5-(N-
4-methyl phenylamino methyleno) mangiferin, 5-(N-
p-methoxy phenylamino methyleno) mangiferin, 5-(N, 
N-diphenylamino methyleno) mangiferin, 5-(N-毩
-napthylamino methyleno) mangiferin were synthesized. 
The synthesized mangiferin analogues were characterized 
by Rf, mp, UV, IR and NMR spectral analyses. The absorbed 
maxima 205.6, 256.8, 238.4, 315.2 and 367.2 nm of mangiferin 
is closely related to that of reported UV spectral data[12]. 
Mangiferin and its derivative were also confirmed by proton 
NMR signals. Subcutaneous injection of BY markedly 
increase the mice rectal temperature. Elevation in body 
temperature in response to an invasive or infectious agent 
is known as fever. Invasive agents like BY are known to 
stimulate synthesis of various cytokines (TNF-毩, IL-1, 
IL-6). The pyretic effect of BY was maintained for more than 
3 hr after drug or vehicle treatment. Mangiferin has been 
previously reported to have anti-inflammatory properties. 
Recent study has shown that mangiferin inhibits TNF-毩 
synthesis. Mangiferin also has been reported to possess 
anti-oxidant activity which is useful for amelioration 
of inflammatory actions of cytokines. Similar results 
were observed in the previous study. All the analogues 
of mangiferin in both the doses (100 mg/kg and 200 mg/
kg) as well as ASA had significantly decreased the rectal 
temperature up to 3 hr. Lower doses (100 mg/kg) of M-1, 
M-2 and M-4 were not able to reduce the rectal temperature 
within 1 h. M-1 (100 mg/kg) and M-4 (100 mg/kg) had 
significantly decreased temperature after 2 h, whereas M-2 
(100 mg/kg) had shown anti pyretic effect after 3 h. Higher 
doses of analogues were more effective in decreasing the 
rectal temperature than lower doses. All the analogues 
in higher doses had shown anti pyretic activity at 1 h and 
the activity was sustained up to 3 h. These observations of 
present study reveal that the mangiferin and mangiferin 
analogues have antipyretic activity.
  From the present study it can be concluded that the 
synthesized analogue along with mangiferin showed a 
significant antipyretic activity. The activity may be due 
to the anti-inflammatory and antioxidant potential of 
mangiferin or its analogues. However, further investigations 
are required to know the exact mechanism of action which 
may prove it to be a potential antipyretic agent. 
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